Molecular Medicine Reports Molecular Medicine Reports 1791-2997 1791-3004 D.A. Spandidos 10.3892/mmr.2016.5857 mmr-14-06-5211 Articles Alterations in ACE and ABCG2 expression levels in the testes of rats subjected to atropine-induced toxicity LiXue-Fang 1 HuangQuan-Yong 2 YangWen-Zhong 2 WangHui-Jie 3 LiCan-Wei 4 Library of Dali University, Dali, Yunnan 671003, P.R. China Department of Pathology, School of Basic Medical Sciences, Dali University, Dali, Yunnan 671000, P.R. China Department of Histology and Embryology, School of Basic Medical Sciences, Dali University, Dali, Yunnan 671000, P.R. China Department of Epidemiology and Health Statistics, School of Public Health, Dali University, Dali, Yunnan 671000, P.R. China Correspondence to: Dr Quan-Yong Huang, Department of Pathology, School of Basic Medical Sciences, Dali University, Building 1F, Block D, Xiaguan Wanhua Road, Dali, Yunnan 671000, P.R. China, E-mail: hqy0726@126.com 122016 19102016 14 6 5211 5216 07102015 20072016 Copyright © 2016, Spandidos Publications 2016

Atropine-induced damage is associated with enzyme and protein alterations. The aim of the present study was to investigate atropine-induced alterations in testicular expression levels of angiotensin-converting enzyme (ACE) and adenosine 5′-triphosphate binding cassette sub-family G member 2 (ABCG2) following atropine treatment. Male Wistar rats received 15 mg/kg/day atropine for 7 days; control rats received an identical volume of saline, Following treatment, the testes were harvested for immunohistochemistry and in situ hybridization to examine the protein and gene expression levels of ACE and ABCG2 by digital image analysis. ACE gene and protein expression levels were significantly reduced in the testes of atropine-treated rats, compared with control rats (P=0.0001 and P<0.001, respectively). In addition, ABCG2 gene and protein expression levels were significantly increased in the testes of atropine-treated rats, compared with control rats (P=0.0017 and P<0.001, respectively). Thus, the results of the present study demonstrate that testicular protein and gene expression levels of ACE and ABCG2 were altered as a result of atropine-induced toxicity in the rats. These alterations may result in abnormal testicular function, and the proteins and genes identified in the present study may be useful to elucidate the mechanisms underlying atropine-induced toxicity and provide a direction for further studies.

 angiotensin-converting enzyme adenosine 5′-triphosphate binding cassette subfamily G member 2 testes rat atropine-induced Introduction

Atropine sulfate is an anticholinergic drug with a wide spectrum of activity (1), exerting diverse effects on numerous systems. Rapid administration of atropine during resuscitation may be life-saving (2). Atropine has also been used for the treatment of anticholinesterase pesticide poisoning (3), bradycardia and associated hypotension (4). In addition, atropine may significantly slow the progression of myopia in children (5). Furthermore, atropine has been demonstrated to have a significant anti-emetic effect (6).

Although the importance of atropine in the treatment of organophosphate poisoning is generally recognized, numerous side effects of atropine have been reported, suggesting potential toxicity (7). Atropine used in dobutamine stress echocardiograms has been reported to cause morbidity (8). Atropine has been shown to be cytotoxic to human corneal epithelial cells via the induction of cell cycle arrest and death receptor-mediated mitochondrion-dependent apoptosis (9). In the heart, atropine toxicity resulted in altered expression levels of E-cadherin and serotonin (10), and in the lung, atropine decreased pulmonary gas exchange in a dose-dependent manner (11). In addition, atropine alters pulse rate, pupil diameter and salivary flow (12). The use of atropine eye drops has been reported to cause significant toxicity (13), and a dose of atropine 1% may result in pupillary mydriasis and accommodative paralysis (14). Previous studies have demonstrated that atropine is primarily involved in decreasing male fertility by inhibiting the transport of sperm and semen in rats (15). In addition, the angiotensin-converting enzyme (ACE) and adenosine 5′-triphosphate binding cassette sub-family G member 2 (ABCG2) were observed to be altered in the testes in some conditions, such as selenium-induced toxicity (16,17). However, the alterations in ACE and ABCG2 expression levels in the testes following atropine-induced toxicity remain to be elucidated.

The present study performed immunohistochemistry and in situ hybridization (ISH) to evaluate the expression levels of ACE and ABCG2 in the testes, and determine whether protein and gene expression levels were altered by atropine-induced toxicity.

 Materials and methods <sec> <title>Animals and study design

A total of 16 healthy adult male Wistar rats, (age, 2 months; weight, 210–250 g; Sun Yat-sen University, Guangzhou, China), were used for the purposes of the present study. All animals were housed individually in stainless-steel wire-bottom cages in an air-conditioned room at a temperature of 25°C, 50% relative humidity and a 12-h light/dark cycle. Rats had free access to standard pellet chow and water throughout the experimental period. All procedures described in the present study were approved by the ethics committee of Dali University (Dali, China).

Animals were randomly assigned to one of two groups (n=8 rats/group): The atropine group, which received intraperitoneal injections of a physiological dose of 15 mg/kg/day atropine for seven days (one injection per day) and the control group, which received identical volumes of normal saline for seven days (10).

On day eight, the control and experimental animals were deeply anesthetized with 1% sodium pentobarbital, (Harbin Pharmaceutical Group, Co., Ltd., Harbin, China) and the testes were removed. The testes were harvested for histopathology, immunohistochemistry and ISH.

 Histopathology

Testicular tissues were fixed in phosphate-buffered 4% formalin (pH 7.4) for 24 h and embedded in paraffin. Testes were sectioned (4-µm) on a microtome and stained with hematoxylin and eosin. The slides were coded, and semiquantitative analysis of the sections was performed in a blinded manner by a pathologist using a light microscope. Histopathological alterations were evaluated as described previously (18,19).

 Immunohistochemistry

Testes were immersed in 4% formaldehyde in phosphate-buffered saline (PBS; pH 7.2), embedded in paraffin and sectioned coronally (4-µm) on a microtome. Sections were deparaffinized, and immersed in 0.3% H2O2 in PBS for 10 min followed by 1% normal goat serum in PBS for 3 min to reduce nonspecific reactions. Primary mouse anti-ACE (dilution, 1:400; cat. no. sc-23908; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) or rabbit anti-ABCG2 (dilution, 1:400; cat. no. sc-130933; Santa Cruz Biotechnology, Inc.) antibodies were added to sections and incubated overnight at 4°C. Subsequently, sections were washed three times in PBS and incubated with biotin-conjugated goat anti-mouse and goat anti-rabbit IgG secondary antibodies (cat. nos. sc-23908 and sc-130933, respectively; dilution, 1:400; Santa Cruz Biotechnology, Inc.) for 1 h at room temperature. Following five washes with PBS, tissue sections were incubated for 10 min in streptavidin-peroxidase (horseradish peroxidase; Santa Cruz Biotechnology, Inc.) and then washed three further times with PBS. Bound antibody was visualized with diaminobenzidine (DAB), and sections were counterstained with hematoxylin according to the methods described previously (20–22). PBS was substituted for primary antibody as the negative control.

 ISH

ACE and ABCG2 genes were detected using ISH kits purchased from Wuhan Boster Biological Technology, Ltd., Wuhan, China (catalog nos. MK-2335 and MK-2675, respectively). ISH was performed according to the manufacturer's instructions, with slight modifications. Briefly, slides were denatured with 70% formamide in 2X saline sodium citrate buffer at 65°C for 10 min. The probe mixture was denatured at 65°C, incubated at 37°C for 10 min and subsequently applied to the slides in a moist chamber. Following overnight hybridization, slides were washed with PBS for 5 min. Positive signals were visualized with DAB and sections were counterstained with hematoxylin. The slides were dried at room temperature (23).

 Image processing

Total integrated optical density (IOD), a parameter representing ACE and ABCG2 expression levels in testicular tissue, was determined using a microscope (BX41; Olympus Corporation, Tokyo, Japan), digital camera (DP-10; Olympus Corporation) and image-analysis program (MetaMorph software version 4.65; Molecular Devices, LLC, Sunnyvale, CA, USA). A total of five images were captured of each immuno- and ISH-stained section (magnification, ×200) from eight rats, which were used to calculate the mean (21,22).

 Statistical analysis

Data are expressed as the mean ± standard error. The total IOD of the two groups was compared using Kruskal-Wallis analysis. P<0.05 was considered to indicate a statistically significant difference. All analyses were performed in SPSS version 12.0 (SPSS Inc., Chicago, IL, USA).

 Results <sec> <title>Histological examination

Hematoxylin and eosin staining did not reveal any morphological differences in rat testes between the two groups (data not shown).

 Expression levels of ACE protein

ACE staining was detected primarily in the tubule lumen, as fine brown granular staining. Sections were independently verified by two observers in order to confirm the results.

The photomicrographs in Fig. 1 reveal ACE staining in control (Fig. 1A) and atropine-injured (Fig. 1B) testes. Total IOD of ACE in testes from rats that had undergone atropine intoxication was significantly reduced compared with control rats (0.0049±0.00057 vs. 0.0063±0.00039; P=0.0001; Table I).

 Expression levels of ABCG2 protein

ABCG2 staining was detected primarily in the tubule lumen, as fine brown granular staining.

ABCG2 staining was performed on the testes of control (Fig. 2A) and atropine-treated (Fig. 2B) rats. Total IOD of ABCG2 in testes from rats subjected to atropine intoxication was significantly increased compared with control rats (0.0072±0.00063 vs. 0.0059±0.00071; P=0.0017; Table I).

 Expression levels of ACE DNA

ISH of ACE DNA was detected primarily in the tubule lumen of testicular tissue from control (Fig. 3A) and atropine-exposed (Fig. 3B) rats. Total IOD of ACE in testes from rats subjected to atropine exposure was significantly reduced compared with control rats (0.0047±0.00046 vs. 0.0062±0.00035: P<0.001; Table II).

 Expression levels of ABCG2 DNA

ISH of ABCG2 DNA was detected primarily in the tubule lumen of testicular tissue from control (Fig. 4A) and atropine-exposed (Fig. 4B) rats. Total IOD of ABCG2 in testes from rats subjected to atropine exposure was significantly increased compared with control rats (0.0070±0.00027 vs. 0.0059±0.00016; P<0.001; Table II).

 Discussion

Although atropine is widely used, its undesirable side effects may markedly decrease quality of life.

ACE is involved in the physiology of the vasculature, blood pressure and inflammation (24). It has been demonstrated that the insertion/deletion (I/D) ACE gene polymorphism is associated with coronary restenosis (25), and may also affect blood pressure (26) and pregnancy-induced hypertension (27). ACE is one of the factors controlling blood pressure (28). The I/D polymorphism has been associated with nitric oxide metabolite levels and systolic blood pressure in men (29), and high blood pressure at the end of pregnancy in women (30). Abnormal expression of ACE in rats resulted in inflammation, pulmonary edema and histological changes in smoke inhalation-induced lung injury (31). In humans, the I/D polymorphism of the ACE gene has been associated with the development of high altitude pulmonary edema (32).

The I/D ACE polymorphism has been demonstrated to be independent of thrombosis formation (33); however, it may be associated with osteoporosis (34), panic disorder (35) and vitiligo (36).

In the present study, the expression levels of ACE in the testes of atropine-exposed rats were significantly reduced when compared with control rats. This suggests the ACE may be associated with testicular injury (37). For example, atropine may inhibit the muscarinic acetylcholine receptor (mACh) -receptor leading to abnormal gland function (38). These alterations may influence ACE expression and the subsequent conversion of angiotensin (39,40).

ABCG2 actively transports numerous endogenous and exogenous substrates across membranes (41). ABCG2 is involved in drug-resistance in cancer (42), as overexpression results in the ejection of drugs from cancer cells (43). In addition, ABCG2 overexpression promotes proliferation and suppresses apoptosis (44,45). Furthermore, ABCG2 may affect the oral availability, tissue distribution and excretion of its substrates (46).

ABCG2 has been demonstrated to be overexpressed in various solid tumors, acute myelogenous leukemia and chronic myeloid leukemia (47), and is a potential biomarker of multidrug resistance in non-small cell lung cancer (48). In addition, ABCG2 is involved in amyloid β transport and was revealed to be significantly upregulated in Alzheimer's disease (49). ABCG2 staining may be a potential novel independent prognostic factor in colorectal cancer (50) and may be involved in hepatocellular carcinoma drug resistance (51) It has been demonstrated that ABCG2 is critical in cardiovascular and cancer pathophysiology (52). Furthermore, ABGG2 is overexpressed in acute myeloid leukemia patients with an increased risk of relapse (53).

Targeted inhibition of ABCG2 has been demonstrated to improve the efficacy of cancer therapeutics (54). Statins may downregulate ABCG2 expression and function by reducing low-density lipoprotein cholesterol levels (55). However, ABCG2 deficiency may increase oxidative stress, alter the inflammatory response in the brain and exacerbate cognitive deficits (56).

In the present study, the expression levels of ABCG2 in the testes of atropine-exposed rats were significantly increased compared with control rats. This suggests that ABCG2 may be associated with testicular injury, and influence the homeostasis of testes tissues and cells, such as the blood-testis barrier (57).

In conclusion, the results of the present study demonstrate that ACE expression levels were significantly reduced, while ABCG2 expression levels were significantly elevated, in response to atropine exposure. These alterations may be reflected in abnormal testicular function, including sperm production and motility, due to disruption of the normal homeostasis of testes tissues and cells. The proteins and genes investigated in the present study may be useful to elucidate the mechanisms underlying atropine-induced toxicity and provide directions for future studies, such as the development of therapies that activate the mACh receptor, as well as protect sperm production and motility during atropine treatment.

 Acknowledgements

The present study was supported by grants from the National Natural Science Foundation of China (grant no. 81260466) and Dali University (grant no. KYBS201104).

 References ByadagiKSNandibewoorSTChimatadarSACatalytic activity of ruthenium (III) on the oxidation of an anticholinergic drug-atropine sulfate monohydrate by copper (III) periodate complex in aqueous alkaline medium - decarboxylation and free radical mechanismActa Chim Slov60617627201324169716 KonickxLABinghamKEddlestonMIs oxygen required before atropine administration in organophosphorus or carbamate pesticide poisoning? - A cohort studyClin Toxicol (Phila)52531537201410.3109/15563650.2014.915411248107964134047 PapoutsisINikolaouPSpiliopoulouCPistosCStefanidouMAthanaselisSA simple and sensitive GC/MS method for the determination of atropine during therapy of anticholinesterase poisoning in serum samplesDrug Test Anal4229234201210.1002/dta.34321998036 StephensonMWongARotellaJACrumpNKerrFGreeneSLDeliberate fingolimod overdose presenting with delayed hypotension and bradycardia responsive to atropineJ Med Toxicol10215218201410.1007/s13181-013-0354-3241789034057535 LiSMWuSSKangMTLiuYJiaSMLiSYZhanSYLiuLRLiHChenWAtropine slows myopia progression more in Asian than white children by meta-analysisOptom Vis Sci91342350201424445721 BaciarelloMCorniniAZasaMPedronaPScrofaniGVenutiFSFanelliGIntrathecal atropine to prevent postoperative nausea and vomiting after Cesarean section: A randomized, controlled trialMinerva Anestesiol77781788201121730925 JandrićZRathorMNChhem-KiethSAdu-GyamfiJMayrLReschCBadoSŠvarc-GajićJCannavanAUptake of (14)C-atropine and/or its transformation products from soil by wheat (Triticum aestivum var Kronjet) and their translocation to shootsJ Environ Sci Health B4810341042201310.1080/03601234.2013.82428124007480 WilsonMELeeGKChandraAKaneGCCentral anticholinergic syndrome following dobutamine-atropine stress echocardiographyEchocardiography28E205E206201110.1111/j.1540-8175.2011.01509.x21929583 TianCLWenQFanTJCytotoxicity of atropine to human corneal epithelial cells by inducing cell cycle arrest and mitochondrion-dependent apoptosisExp Toxicol Pathol67517524201510.1016/j.etp.2015.07.00626296992 HuangQYLiXFLiuSPE-cadherin and 5-HT alterations in the heart of rats having undergone atropine-induced toxicityMol Med Rep5700704201222200906 GaspariRJPaydarfarDPulmonary effects of intravenous atropine induce ventilation perfusion mismatchCan J Physiol Pharmacol92399404201410.1139/cjpp-2012-042924773405 FryJRBurrSAA double-blind atropine trial for active learning of autonomic functionAdv Physiol Educ35438444201110.1152/advan.00075.201122139783 StellpflugSJColeJBIsaacsonBALintnerCPBildenEFMassive atropine eye drop ingestion treated with high-dose physostigmine to avoid intubationWest J Emerg Med137779201210.5811/westjem.2011.7.6817224619273298216 CooperJEisenbergNSchulmanEWangFMMaximum atropine dose without clinical signs or symptomsOptom Vis Sci9014671472201310.1097/OPX.000000000000003724076540 SatoTBanYUchidaMGondoEYamamotoMSekiguchiYSakaueAKemiMNakatsukaTAtropine-induced inhibition of sperm and semen transport impairs fertility in male ratsJ Toxicol Sci30207212200510.2131/jts.30.20716141654 Hahnova-CygalovaLCeckovaMStaudFFetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): Expression and function throughout pregnancyDrug Metab Rev435368201110.3109/03602532.2010.51229320854129 KhalidAKhudhairNHeHPengZYaguangTGuixueZEffects of dietary selenium supplementation on seminiferous tubules and SelW, GPx4, LHCGR and ACE expression in chicken testisBiol Trace Elem Res173202209201610.1007/s12011-016-0646-y26899318 HelinHOLundinMELaaksoMLundinJHelinHJIsolaJVirtual microscopy in prostate histopathology: Simultaneous viewing of biopsies stained sequentially with hematoxylin and eosin and alpha-methylacyl-coenzyme A racemase/p63 immunohistochemistryJ Urol175495499200610.1016/S0022-5347(05)00164-316406979 De RossiARochaLBRossiMAApplication of fluorescence microscopy on hematoxylin and eosin-stained sections of healthy and diseased teeth and supporting structuresJ Oral Pathol Med36377381200710.1111/j.1600-0714.2007.00542.x17559501 SmithPSParkinsonIHLeongASPrinciples of ploidy analysis by static cytometryClin Mol Pathol49M104M111199610.1136/mp.49.2.M10416696050408030 DongJYinHLiuWWangPJiangYChenJCongenital iodine deficiency and hypothyroidism impair LTP and decrease C-fos and C-jun expression in rat hippocampusNeurotoxicology26417426200510.1016/j.neuro.2005.03.00315935212 van KuijkAWGerlagDMVosKWolbinkGde GrootMde RieMAZwindermanAHDijkmansBATakPPA prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: Effects of adalimumab treatment on synovial tissueAnn Rheum Dis6813031309200910.1136/ard.2008.091389186478512703703 SeoHWHanKOhYKangIParkCJooHEKimSHLeeBHChaeCEvaluation of commercial polyclonal- and monoclonal-antibody-based immunohistochemical tests for 2 genotypes of Porcine circovirus type 2 and comparison with in-situ hybridization assaysCan J Vet Res782332362014249825564068416 RashedLHayR AbdelMahmoudRHasanNZahraAFayezSAssociation of Angiotensin-Converting Enzyme (ACE) gene polymorphism with inflammation and cellular cytotoxicity in vitiligo patientsPLoS One10e0132915201510.1371/journal.pone.0132915261771004503778 MiaoHWGongHAssociation of ACE insertion or deletion polymorphisms with the risk of coronary restenosis after percutaneous coronary intervention: A meta-analysisJ Renin Angiotensin Aldosterone Syst16844850201510.1177/147032031558823326195267 GoesslerKFCornelissenVAde OliveiraEMde MotaFGPolitoMDACE polymorphisms and the acute response of blood pressure to a walk in medicated hypertensive patientsJ Renin Angiotensin Aldosterone Syst16720729201510.1177/147032031560008626297704 MiaoHWGongHCorrelation of ACE gene deletion/insertion polymorphism and risk of pregnancy-induced hypertension: A meta-analysis based on 10,236 subjectsJ Renin Angiotensin Aldosterone Syst16982994201510.1177/147032031558887226071453 Betancur-AnconaDDávila-OrtizGChel-GuerreroLATorruco-UcoJGACE-I inhibitory activity from phaseolus lunatus and phaseolus vulgaris peptide fractions obtained by ultrafiltrationJ Med Food1812471254201510.1089/jmf.2015.000726061663 Avila-VanzziniNPosadas-RomeroCGonzalez-Salazar MdelCMaass-IturbideCMelendez-RamirezGPerez-MendezODel Valle-MondragonLMasso-RojasFLopezE VarelaHerrera-BelloHThe ACE I/D polymorphism is associated with nitric oxide metabolite and blood pressure levels in healthy Mexican menArch Cardiol Mex85105110201525700580 ReshetnikovEAAkulovaLYDobrodomovaISDvornykVYPolonikovAVChurnosovMIThe insertion-deletion polymorphism of the ACE gene is associated with increased blood pressure in women at the end of pregnancyJ Renin Angiotensin Aldosterone Syst16623632201510.1177/147032031350121724150610 YilinZYandongNFaguangJRole of angiotensin-converting enzyme (ACE) and ACE2 in a rat model of smoke inhalation induced acute respiratory distress syndromeBurns4114681477201510.1016/j.burns.2015.04.01025981293 BhagiSSrivastavaSTomarABalaSSSarkarSPositive association of D allele of ACE gene with high altitude pulmonary edema in indian populationWilderness Environ Med26124132201510.1016/j.wem.2014.09.01025683681 GorukmezOSagŞOGorukmezÖTureMTopakASahinturkSOzkayaGGultenTAliRYakutTAssociation of the ACE I/D gene polymorphisms with JAK2V617F-positive polycythemia vera and essential thrombocythemiaGenet Test Mol Biomarkers19303308201510.1089/gtmb.2014.033425955555 CakmakBInanirAKarakusNAtesOYigitSAssociation between the ACE gene I/D polymorphism and osteoporosis in a Turkish populationZ Rheumatol74346350201510.1007/s00393-015-1582-525876051 Gulec-YilmazSGulecHDalanABCetınBTımırcı-KahramanOOgutDBAtasoyHDırımenGAGultekınGIIsbırTThe relationship between ACE polymorphism and panic disorderIn Vivo28885889201425189904 BadranDINadaHHassanRAssociation of Angiotensin-Converting Enzyme ACE gene polymorphism with ACE activity and susceptibility to Vitiligo in Egyptian populationGenet Test Mol Biomarkers19258263201510.1089/gtmb.2014.032625807210 FujiharaYTokuhiroKMuroYKondohGArakiYIkawaMOkabeMExpression of TEX101, regulated by ACE, is essential for the production of fertile mouse spermatozoaProc Natl Acad Sci USA11081118116201310.1073/pnas.1222166110236335673657793 ShiCLTäljedalIBMattssonMOEffect of carbachol on regulation of the mACh receptor mRNA expression ADN insulin secretion in mouse pancreatic isletsActa Physiol Scand167A18199910.1046/j.1365-201x.1999.0600v.x10571577 BalyasnikovaIVMetzgerRFrankeFEConradNTowbinHSchwartzDESturrockEDDanilovSMEpitope mapping of mAbs to denatured human testicular ACE (CD143)Tissue Antigens72354368200810.1111/j.1399-0039.2008.01112.x18700874 RushworthCAGuyJLTurnerAJResidues affecting the chloride regulation and substrate selectivity of the angiotensin-converting enzymes (ACE and ACE2) identified by site-directed mutagenesisFEBS J27560336042200810.1111/j.1742-4658.2008.06733.x19021774 SchnepfRZolkOEffect of the ATP-binding cassette transporter ABCG2 on pharmacokinetics: Experimental findings and clinical implicationsExpert Opin Drug Metab Toxicol9287306201310.1517/17425255.2013.74206323289909 ErdeiZSarkadiBBrózikASzebényiKVáradyGMakóVPéntekAOrbánTIApátiÁDynamic ABCG2 expression in human embryonic stem cells provides the basis for stress responseEur Biophys J42169179201310.1007/s00249-012-0838-022851001 YangBMaYFLiuYElevated expression of Nrf-2 and ABCG2 involved in multi-drug resistance of lung cancer SP cellsDrug Res (Stuttg)65526531201525368906 XieJJinBLiDWShenBCongNZhangTZDongPABCG2 regulated by MAPK pathways is associated with cancer progression in laryngeal squamous cell carcinomaAm J Cancer Res46987092014255208614266705 KalaliniaFElahianFMosaffaFBehravanJCelecoxib up regulates the expression of drug efflux transporter ABCG2 in breast cancer cell linesIran J Pharm Res13139314012014255873294232806 Lecerf-SchmidtFPeresBValdameriGGauthierCWinterEPayenLDi PietroABoumendjelAABCG2: Recent discovery of potent and highly selective inhibitorsFuture Med Chem510371045201310.4155/fmc.13.7123734686 JuvaleKWieseMDesign of inhibitors of BCRP/ABCG2Future Med Chem715211527201510.4155/fmc.15.8326293476 WangDSPatelAShuklaSZhangYKWangYJKathawalaRJRobeyRWZhangLYangDHTaleleTTIcotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2Oncotarget545294542201410.18632/oncotarget.2102249808284147343 FehérÁJuhászALászlóAPákáskiMKálmánJJankaZAssociation between the ABCG2 C421A polymorphism and Alzheimer's diseaseNeurosci Lett5505154201310.1016/j.neulet.2013.06.04423827224 WangXXiaBLiangYPengLWangZZhuoJWangWJiangBMembranous ABCG2 expression in colorectal cancer independently correlates with shortened patient survivalCancer Biomark138188201323838136 HouHSunHLuPGeCZhangLLiHZhaoFTianHZhangLChenTTunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse Xenograft models of human hepatocellular carcinomaMol Cancer Ther1228742884201310.1158/1535-7163.MCT-13-020124130050 DeppeSRippergerAWeissJErgunSBenndorfRAImpact of genetic variability in the ABCG2 gene on ABCG2 expression, function, and interaction with AT1 receptor antagonist telmisartanBiochem Biophys Res Commun44312111217201410.1016/j.bbrc.2013.12.11924388985 DamianiDTiribelliMGerominAMicheluttiACavallinMSperottoAFaninRABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcomeAm J Hematol90784789201510.1002/ajh.2408426059733 LinYHChangHMChangFPShenCRLiuCLMaoWYLinCCLeeHSShenCNProtoporphyrin IX accumulation disrupts mitochondrial dynamics and function in ABCG2-deficient hepatocytesFEBS Lett58732023209201310.1016/j.febslet.2013.08.01123954234 ToKKHuMTomlinsonBExpression and activity of ABCG2, but not ABCB1 or OATP1B1, are associated with cholesterol levels: Evidence from in vitro and in vivo experimentsPharmacogenomics1510911104201410.2217/pgs.14.5825084202 ZengYCallaghanDXiongHYangZHuangPZhangWAbcg2 deficiency augments oxidative stress and cognitive deficits in Tg-SwDI transgenic miceJ Neurochem122456469201210.1111/j.1471-4159.2012.07783.x22578166 NatarajanKXieYBaerMRRossDDRole of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistanceBiochem Pharmacol8310841103201210.1016/j.bcp.2012.01.002222487323307098

Effect of atropine exposure on ACE protein expression levels in rat testes. Photomicrographs reveal ACE staining in testes from (A) control and (B) atropine-treated rats. Positive immunostaining appears as brown staining. Total ACE integrated optical density in the testes of rats subjected to atropine exposure was significantly reduced compared with control rats (Table I; P<0.05). Magnification, ×200. ACE, angiotensin-converting enzyme.

Effect of atropine exposure on ABCG2 protein expression levels in rat testes. Photomicrographs reveal ABCG2 staining in testes from (A) control and (B) atropine-treated rats. Positive immunostaining appears as brown staining. Total ABCG2 integrated optical density in the testes of rats subjected to atropine exposure was significantly increased compared with control rats (Table I; P<0.05). Magnification, ×200. ABCG2, adenosine 5′-triphosphate binding cassette subfamily G member 2.

Effect of atropine exposure on ACE gene expression levels in rat testes. Photomicrographs reveal ISH of ACE DNA in testes from (A) control and (B) atropine-treated rats. Positive ISH staining appears as brown staining. Total ACE integrated optical density in the testes of rats subjected to atropine exposure was significantly reduced compared with control rats (Table II; P<0.05). Magnification, ×200. ACE, angiotensin-converting enzyme; ISH, in situ hybridization.

Effect of atropine exposure on ABCG2 gene expression levels in rat testes. Photomicrographs reveal ISH of ABCG2 DNA in testes from (A) control and (B) atropine-treated rats. Positive ISH staining appears as brown staining. Total ABCG2 integrated optical density in the testes of rats subjected to atropine exposure was significantly increased compared with control rats (Table II; P<0.05). Magnification, ×200. ABCG2, adenosine 5′-triphosphate binding cassette subfamily G member 2; ISH, in situ hybridization.

IOD of ACE and ABCG2 proteins in rat testes.

Group ACE ABCG2
Control 0.0063±0.00039 0.0059±0.00071
Atropine-treated
P-value 0.0049±0.00057 0.0072±0.00063
0.0001 0.0017

ACE and ABCG2 were detected in rat testes by immunohistochemistry. IOD is a measure of staining levels. A total of five images were captured of each section. Data are expressed as the mean ± standard error. IOD, integrated optical density; ACE, angiotensin-converting enzyme; ABCG2, adenosine 5′-triphosphate binding cassette subfamily G member 2.

IOD of ACE and ABCG2 genes in rat testes.

Group ACE ABCG2
Control 0.0062±0.00035 0.0059±0.00016
Atropine-treated 0.0047±0.00046 0.0070±0.00027
P-value <0.001 <0.001

ACE and ABCG2 were detected in rat testes by in situ hybridization. IOD is a measure of staining levels. A total of five images were captured of each section. Data are expressed as the mean ± standard error. IOD, integrated optical density; ACE, angiotensin-converting enzyme; ABCG2, adenosine 5′-triphosphate binding cassette subfamily G member 2.